0000912282-24-000460.txt : 20240528 0000912282-24-000460.hdr.sgml : 20240528 20240528144831 ACCESSION NUMBER: 0000912282-24-000460 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240523 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans Daron CENTRAL INDEX KEY: 0001411726 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39683 FILM NUMBER: 24990910 MAIL ADDRESS: STREET 1: C/O NEPHROS, INC. STREET 2: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rezolute, Inc. CENTRAL INDEX KEY: 0001509261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 273440894 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 275 SHORELINE DRIVE, SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-206-4507 MAIL ADDRESS: STREET 1: 275 SHORELINE DRIVE, SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: AntriaBio, Inc. DATE OF NAME CHANGE: 20130114 FORMER COMPANY: FORMER CONFORMED NAME: FITS MY STYLE INC DATE OF NAME CHANGE: 20110104 4 1 form4.xml X0508 4 2024-05-23 0001509261 Rezolute, Inc. RZLT 0001411726 Evans Daron C/O REZOLUTE, INC. 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 true CFO false Common Shares 2024-05-23 4 P 0 58 2.85 A 10058 I Held by minor child #1 Common Shares 2024-05-24 4 P 0 2942 3.23 A 13000 I Held by minor child #1 Common Shares 120900 D Common Shares 20000 I Held by spouse Common Shares 4500 I Held by minor child #2 Common Shares 4500 I Held by minor child #3 The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.21 to $3.23, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. /s/ Daron Evans 2024-05-28